NEW YORK (GenomeWeb) – Contract research organization Helomics and molecular diagnostics firm MDNA today announced a partnership broadening access to MDNA's tests.

As part of the deal, Helomics will promote MDNA's Prostate Core Mitomic Test and its liquid biopsy Prostate Mitomic Test in select US markets. Helomics will also offer the tests in its CLIA-approved clinical laboratory.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.